DCMIC
RXDX
Decheng Capital Management III (Cayman)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-150,000
| Closed | -$16.1M | – | 29 |
|
|
2023
Q1 | $16.1M | Sell |
150,000
-100,000
| -40% | -$10.7M | 6.49% | 7 |
|
|
2022
Q4 | $27.5M | Hold |
250,000
| – | – | 10.29% | 3 |
|
|
2022
Q3 | $14.8M | Hold |
250,000
| – | – | 5.35% | 6 |
|
|
2022
Q2 | $7.06M | Hold |
250,000
| – | – | 2.68% | 11 |
|
|
2022
Q1 | $9.44M | Buy |
+250,000
| New | +$9.44M | 2.89% | 12 |
|